Munafa Stock Market Course + Intraday & FNO calls 
Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Fate Therapeutics (FATE)
Technical Analysis Report for USA stock FATE Fate Therapeutics. Dated: 09 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock FATE Fate Therapeutics then click here. or read Experts views on Fate Therapeutics or Forecast & share price targets of Fate Therapeutics
Fate Therapeutics Opened at 1.08 and Closed at: 1.05, which is -1.9% of previous session's close. It moved within a range of 1.04 and 1.10
The session was a Bearish session with an average volume of 925400, which is -33.08% of previous session's volumes.
A Golden cross was found 5 days back on short term averages
Support for tomorrow is 1.02 and resistance for tomorrow is 1.08
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.03, 1 resistance for tomorrow's hourly charts is 1.09, 1.12
10 Day SMA for Fate Therapeutics (FATE) is 1.07 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Fate Therapeutics (FATE) is 1.05 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Fate Therapeutics (FATE) is 1.25 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.16 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Fate Therapeutics is 1.13 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Fate Therapeutics is at 1.05 and 200 DMA is at 1.13, while 50 DMA and 100 DMA are at 1.25 and 1.16 respectively
Fate Therapeutics (FATE) moving average of 20 SMA is at 1.05 and 20 EMA is at 1.1
| Date | Closing Price | 20 SMA | 20 EMA |
| 09 Tue Dec | 1.05 | 1.05 | 1.1 |
| 08 Mon Dec | 1.07 | 1.05 | 1.1 |
| 05 Fri Dec | 1.08 | 1.05 | 1.1 |
| 04 Thu Dec | 1.11 | 1.05 | 1.1 |
| 03 Wed Dec | 1.08 | 1.05 | 1.1 |
| 02 Tue Dec | 1.00 | 1.05 | 1.1 |
Fate Therapeutics (FATE) moving average of 50 SMA is at 1.25 and 50 EMA is at 1.15
| Date | Closing Price | 50 SMA | 50 EMA |
| 09 Tue Dec | 1.05 | 1.25 | 1.15 |
| 08 Mon Dec | 1.07 | 1.25 | 1.15 |
| 05 Fri Dec | 1.08 | 1.25 | 1.15 |
| 04 Thu Dec | 1.11 | 1.25 | 1.15 |
| 03 Wed Dec | 1.08 | 1.24 | 1.15 |
| 02 Tue Dec | 1.00 | 1.24 | 1.15 |
Fate Therapeutics (FATE) moving average of 100 SMA is at 1.16 and 100 EMA is at 1.25
| Date | Closing Price | 100 SMA | 100 EMA |
| 09 Tue Dec | 1.05 | 1.16 | 1.25 |
| 08 Mon Dec | 1.07 | 1.16 | 1.25 |
| 05 Fri Dec | 1.08 | 1.16 | 1.25 |
| 04 Thu Dec | 1.11 | 1.16 | 1.25 |
| 03 Wed Dec | 1.08 | 1.16 | 1.25 |
| 02 Tue Dec | 1.00 | 1.16 | 1.25 |
Fate Therapeutics (FATE) moving average of 200 SMA is at 1.13 and 200 EMA is at 1.46
| Date | Closing Price | 200 SMA | 200 EMA |
| 09 Tue Dec | 1.05 | 1.13 | 1.46 |
| 08 Mon Dec | 1.07 | 1.13 | 1.46 |
| 05 Fri Dec | 1.08 | 1.14 | 1.46 |
| 04 Thu Dec | 1.11 | 1.14 | 1.46 |
| 03 Wed Dec | 1.08 | 1.14 | 1.46 |
| 02 Tue Dec | 1.00 | 1.14 | 1.46 |
Fresenius Medical has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Fresenius Medical, about 0.83% more returns!
Emergent Biosolutions has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Emergent Biosolutions, about 13.05% more returns!
Vertex Pharmaceuticals has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 8.06% more returns!
Sutro Biopharma has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Sutro Biopharma, about 954.4% more returns!
Fate Therapeutics has performed better than Sanofi in short term. Holding Fate Therapeutics could be a better choice for now!
Soligenix Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Soligenix Inc, about 18.22% more returns!
Outlook Therapeutics has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Outlook Therapeutics, about 73.99% more returns!
Orthofix Medical has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Orthofix Medical, about 8.14% more returns!
Fate Therapeutics has performed better than Lexicon Pharmaceuticals in short term. Holding Fate Therapeutics could be a better choice for now!
Kodiak Sciences has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Kodiak Sciences, about 33.86% more returns!
Fate Therapeutics has performed better than Immuron in short term. Holding Fate Therapeutics could be a better choice for now!
Henry Schein has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Henry Schein, about 7.92% more returns!
Galectin Therapeutics has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Galectin Therapeutics, about 14.25% more returns!
Fate Therapeutics has performed better than Eton Pharmaceuticals in short term. Holding Fate Therapeutics could be a better choice for now!
Evolus Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Evolus Inc, about 6.11% more returns!
Arrowhead Pharmaceuticals has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 72.11% more returns!
Apyx Medical has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Apyx Medical, about 8% more returns!
Amneal Pharmaceuticals has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Amneal Pharmaceuticals, about 6.42% more returns!
Achieve Life has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Achieve Life, about 4.36% more returns!
Fate Therapeutics Technical analysis of indicators
Price action analysis of Fate Therapeutics (FATE) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Fate Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Fate Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Fate Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Fate Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.07 and Fate Therapeutics FATE stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Fate Therapeutics FATE stock. Volume based technical analysis of Fate Therapeutics FATE stock is negative.
Fate Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock FATE Fate Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And FATE Experts View which covers a lot of information including buying and selling signals
FATE future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Fate Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
